←back to Blog

A Pilot Investigation of Endocannabinoid System Markers and Lipopolysaccharide Responses to 10 Sessions of Hyperbaric Oxygen Therapy

Med Sci Monit. 2026 Nov 20;32:e953923. doi: 10.12659/MSM.953923.

ABSTRACT

BACKGROUND Hyperbaric oxygen therapy (HBOT) can modulate inflammatory and redox-sensitive pathways, but its effects on endocannabinoid system markers remain unclear. This exploratory biomarker subanalysis of a randomized controlled parent trial evaluated whether repeated HBOT was associated with changes in serum anandamide (AEA) and lipopolysaccharide (LPS) as primary outcomes. Cannabinoid receptor type 2 (CB2R), fatty acid amide hydrolase (FAAH), and the baseline AEA-LPS association were assessed secondarily or exploratorily. MATERIAL AND METHODS The resource-limited, post-randomization sample included 17 healthy, physically active men: 9 from a pre-existing morning scheduling subgroup of the frequent-treatment HBOT arm and 8 controls selected before biomarker assays to improve baseline body mass index (BMI) comparability. HBOT consisted of 10 sessions performed 6 times weekly. Each session involved 60 minutes of 100% oxygen at 2.5 atmospheres absolute, delivered as three 20-min oxygen-breathing periods separated by two 5-minute air breaks. Fasting serum was collected before and after the protocol, and biomarkers were measured using enzyme-linked immunosorbent assays. RESULTS No significant between-group differences in change scores were found for AEA (p = 0.597), CB2R (p=1.000), FAAH (p=0.885), or LPS (p=0.885). No significant within-group changes occurred in the HBOT group. Baseline AEA was positively associated with baseline LPS (Spearman’s rho=0.505, p=0.039). CONCLUSIONS Receiving 10 HBOT sessions were not associated with significant changes in the measured circulating biomarkers. These exploratory findings do not exclude smaller effects, and the baseline AEA-LPS association requires confirmation in adequately powered studies.

PMID:43059161 | DOI:10.12659/MSM.953923